Patent · US Active

Method of lowering serum uric acid levels with (S)-tofisopam

US9408852B2 · kind B2 · utility

0Cited by
3References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 26, 2012
Grant dateAug 9, 2016
Priority date—
Expiry dateNov 22, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P19/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Enantiomerically-pure (S)-tofisopam is administered to lower serum uric acid levels in a mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.